LFWD
Lifeward Ltd.
LFWD has the edge over NVO overall, supported by stronger modeled upside.
NVO
Novo Nordisk A/S
NVO has lower modeled downside risk, despite its lower overall score.
LFWD Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Unavailable |
LFWD's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
LFWD PE Valuation
LFWD has no meaningful PE right now: it lost money over the past year.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
LFWD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
LFWD has the edge over NVO on the outlook, with more favorable earnings and profitability expectations.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
LFWD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$17.23 | +$20.45 |
| Q1 2026 | -$20.07 | +$16.65 |
| Q4 2025 | -$18.89 | +$21.07 |
| Q3 2025 | -$35.88 | -$9.36 |
| Q2 2025 | -$37.68 | -$4.44 |
| Q1 2025 | -$36.72 | -$2.76 |
| Q4 2024 | -$39.96 | -$8.88 |
| Q3 2024 | -$26.52 | +$3.72 |
LFWD is still losing money, but far less than before: $17.23 per share over the past year, against $364.56 at its worst in late 2019.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the edge over LFWD on earnings quality, reporting a profit while its opponent remains loss making.
LFWD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $6.6M | +16% |
| Q1 2026 | $3.9M | -22% |
| Q4 2025 | $5.1M | -33% |
| Q3 2025 | $6.2M | +1.1% |
| Q2 2025 | $5.7M | -15% |
| Q1 2025 | $5M | -4.7% |
| Q4 2024 | $7.5M | +9.6% |
| Q3 2024 | $6.1M | +39% |
LFWD's revenue is down over the past year, though its latest quarter was up: $7M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -63% | +52 points |
| Q1 2026 | -264% | -167 points |
| Q4 2025 | -101% | +101 points |
| Q3 2025 | -51% | +1.1 points |
| Q2 2025 | -115% | -48 points |
| Q1 2025 | -96% | +27 points |
| Q4 2024 | -202% | -113 points |
| Q3 2024 | -52% | +129 points |
LFWD's operating margin was −63% last quarter, up 52 points from the same quarter a year ago.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO has the edge over LFWD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over LFWD on profitability, with a higher operating margin.
LFWD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6M | -$2.1M |
| Q1 2026 | -$3.7M | +$1.8M |
| Q4 2025 | -$3.6M | +$403K |
| Q2 2025 | -$3.9M | +$1.7M |
| Q1 2025 | -$5.5M | +$2.2M |
| Q4 2024 | -$4M | +$594K |
| Q2 2024 | -$5.6M | -$2.1M |
| Q1 2024 | -$7.7M | -$2.4M |
LFWD has burned cash in almost every quarter: −$17M over the past year, against −$19M the year before.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over LFWD on cash generation, producing positive trailing cash flow while its opponent burns cash.
LFWD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +74% | +1.2M shares |
| 1 year | +220% | +1.9M shares |
| 3 years | +295% | +2.1M shares |
| 5 years | +1144% | +2.6M shares |
LFWD has 3M diluted shares, up 220% from a year ago.
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over LFWD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
LFWD Net Leverage
LFWD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
LFWD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.3 | Neutral |
| Stochastic | 22.9 | Neutral |
LFWD's weekly RSI is 39 (neutral) and its Stochastic is 23 (neutral).
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
LFWD PE vs Healthcare Sector
LFWD has no meaningful PE right now: it lost money over the past year.
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
LFWD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.11 | 6.4% below |
| 20 week MA | $6.92 | 17% below |
| 50 week MA | $7.03 | 19% below |
| 100 week MA | $10.4 | 45% below |
| 200 week MA | $32.9 | 83% below |
LFWD is in a downtrend: it's below all five of its weekly moving averages, and 83% below its 200-week average.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has the edge over LFWD on trend strength, trading above more of its moving averages.
LFWD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $186.5 | $136.1 | -27% |
| 2021 | $136.1 | $113.4 | -17% |
| 2022 | $113.4 | $65.5 | -42% |
| 2023 | $65.5 | $65.4 | -0.2% |
| 2024 | $65.4 | $24.1 | -63% |
| 2025 | $24.1 | $7.73 | -68% |
| 2026 YTD | $7.73 | $5.72 | -26% |
LFWD has finished every year since 2020 lower, and it's down 26% so far in 2026.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has the edge over LFWD on returns for 2026, with the stronger performance.